Rituximab exhibits a better safety profile when used as a first line of treatment for pemphigus vulgaris: A retrospective study
Zeinab Aryanian, Kamran Balighi, Maryam Daneshpazhooh, Emad Karamshahi, Parvaneh Hatami, Azadeh Goodarzi, Mahroo Tajalli, Terrence M. Vance
Topics & Concepts
RituximabMedicinePemphigus vulgarisMucocutaneous zoneAdverse effectPemphigusInternal medicineComorbidityRetrospective cohort studyAdjuvantTolerabilityImmunologyDiseaseLymphomaAutoimmune Bullous Skin DiseasesDermatology and Skin DiseasesUrticaria and Related Conditions